HUIZENGA THEODORE ALAN 1603347 Data last updated 2024-05-14 07:02:16 -0500 US CDT
Latest Holdings
Notice: Data summarized from Form 3,4,5 filings, which do not include holdings/transactions of investment institution(s), if any, managed by the reporter.
Non-derivative Transactions CSV download
Tips: type "code_s" to show transactions with code "S".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-10 | 2023-05-09 | 2023-05-09 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | acq | 3000.0 | 9.76 | 0.42 | 21.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code M | 30747.0 | 70.81 (RARE) |
| 2023-09-06 | 2023-09-01 | 2023-09-01 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | dsp | 970.0 | 3.92 | 0.14 | 37.15 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 23777.0
|
71.49 (RARE) |
| 2023-09-11 | 2023-09-07 | 2023-09-07 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | dsp | 2163.0 | 8.39 | 0.3 | 40.8 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code S | 23614.0
|
71.49 (RARE) |
| 2023-09-11 | 2023-09-07 | 2023-09-07 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | acq | 2000.0 | 7.76 | 0.28 | 21.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code M | 25777.0 | 71.49 (RARE) |
| 2023-09-29 | 2023-09-27 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | holding | 23614.0 | 0 | 3.3 | 0.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | NA | 71.49 (RARE) | ||
| 2024-01-02 | 2023-12-20 | 2023-12-20 to 2024-01-02 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | acq | 4000.0 | 14.34 | 0.49 | 15.75 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code A M | 27892.0
|
82.11 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | acq | 13950.0 | 33.34 | 1.7 | 0.0 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code A | 41842.0 | 82.11 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | dsp | 462.0 | 1.1 | 0.06 | 53.74 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code F S | 41380.0
|
82.11 (RARE) |
| 2024-04-18 | 2024-04-16 | 2024-04-16 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | dsp | 14.0 | 0.03 | 0.0 | 42.31 | Direct | Common Stock | ULTRAGENYX PHARMACEUTICAL INC. | code F | 41366.0 | 82.11 (RARE) |
Derivative Transactions
Tips: type "code_m" to show transactions with code "M".
| Filing Date | Transaction Date | Operation Date | Original Filing | Reporter | Relation | Opr | Amounta | %(Owned)b | ‱(SO)c | Avg Prcd | Account | Type | Full Name | Code | Remain | Shares Outstanding (Million)e |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-05-10 | 2023-05-09 | 2023-05-09 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | dsp | 3000.0 | 37.5 | 0.42 | 21.0 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code M | 5000.0 | 70.81 (RARE) |
| 2023-09-11 | 2023-09-07 | 2023-09-07 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | dsp | 2000.0 | 40.0 | 0.28 | 21.0 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code M | 3000.0 | 71.49 (RARE) |
| 2023-09-29 | 2023-09-27 | 2023-09-27 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | acq | 2351.0 | 100.0 | 0.33 | 67.37 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code A | 2351.0 | 71.49 (RARE) |
| 2024-01-02 | 2023-12-20 | 2024-01-02 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | dsp | 3000.0 | 100.0 | 0.37 | 21.0 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code M | 0.0 | 82.11 (RARE) |
| 2024-03-05 | 2024-03-01 | 2024-03-01 | 4 | Huizenga Theodore Alan | SVP, CHIEF ACCOUNTING OFFICER | acq | 10551.0 | 100 | 1.28 | 56.74 | Direct | Stock Option (Right To Buy) | ULTRAGENYX PHARMACEUTICAL INC. | code A | 2351.0
|
82.11 (RARE) |
a Sum of same type of securities in the form
b Relative to reporter's shares owned before (disposition) or after (acquisition) operation
c Relative to issuer's shares outstanding (1/10000)
d Average price for securities of the same type. Check the original form for detailed prices of multiple transactions
e Documented shares outstanding closest to the transaction date
Note: Corporate may change mapped CIK when merge or spin-off happen. Please report error if the ticker you searched for does not have up-to-date insider trading information.
Show up to records per table for current tier. Access Guide)